Synonyms
Alpha-receptor agonists; Oral sympathomimetics; Sympathomimetic decongestants; Systemic decongestants
Definition
Oral decongestants are used to temporarily relieve nasal congestion associated with allergic/nonallergic rhinitis and rhinosinusitis (Gwaltney et al. 1995; Tran et al. 2011). Agents in this class that can be found in both prescription and nonprescription medication include pseudoephedrine and phenylephrine. Despite the efficacy of oral decongestants, these products are becoming more difficult to obtain due to the associated risks. A once popular weight loss agent and decongestant, phenylpropanolamine, was removed from the US market due to increased risk of hemorrhagic stroke (Kernan et al. 2000). Pseudoephedrine was once very accessible over the counter, but now has been moved behind the counter in pharmacies because it is used in the synthesis of methamphetamine. In 2006, the US congress passed the Combat Methamphetamine Epidemic Act of 2005. This act prohibits...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aljazaf K, Hale T, Ilett K, et al. Pseudoephedrine: effects on milk production in women and estimation of infant exposure via breastmilk. Br J Clin Pharmacol. 2003;56:18–24.
Bertrand B, Jamart J, Marchal J et al. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study. Rhinology. 1996;34:91±96.
Bronsky E, Boggs P, Findlay S et al. Comparative efficacy and safety of a once-daily loratadine/pseudoephedrine combination versus its components alone and placebo in the management of seasonal rhinitis. J Allergy Clin Immunol. 1995;96:139±147.
Cantu C, Arauz A, Murillo-Bonilla LM, et al. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003;34:1667–72.
Chua S, Benrimoj S, Triggs E. Pharmacokinetics of non-prescription sympathomimetic agents. Biopharm Drug Dispos. 1989;10(1):1–14.
Corey J, Houser S, Ng B. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J. 2000;79(9):690–3.
Eccles R. Nasal airflow in health and disease. Acta Otolaryngol. 2000;120:580–95.
Fick D, Cooper J, Wade W, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716–24.
Grubbe R, Lumry W, Anolik R. Efficacy and safety of desloratadine/pseudoephedrine combination vs. its components in seasonal allergic rhinitis. J Investig Allergol Clin Immunol. 2009;19(2):117–24.
Gwaltney J, Jones J, Kennedy D. Medical management of sinusitis: educational goals and management guidelines. The International Conference on sinus Disease. Ann Otol Rhinol Laryngol. 1995;167:22–30.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833–8.
Kanfer I, Dowse R, Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy. 1993;13(6 Pt 2):116S–28.
Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826–32.
McEvoy GK, editor. AHFS Drug information 2006. Alpha and Beta-adrenergic Agonists. Bethesda: American Society of Health-System Pharmacists; 2006. p. 1291–1295;1347–49.
Pray W. Challenges when recommending nonprescription products for patients with diabetes. US Pharm. 2010;35(6):8–15.
Pray W, Pray J. Safe use of nasal decongestants. US Pharm. 2004;29(7):22–27.
Taverner D, Danz C, Economos D. The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial. Clin Otolaryngol Allied Sci. 1999;24(1):47–51.
Tietze K. Chapter 12. Disorders related to cold and allergy. In: Berardi R, editor. Handbook of nonprescription drugs. 4th ed. Washington, DC: American Pharmaceutical Association; 2002.
Tran N, Vickery J, Blaiss M. Management of rhinitis: allergic and non-allergic. Allergy Asthma Immunol Res. 2011;3(3):148–56.
Westfall TC, Westfall DP. Chapter 12. Adrenergic agonists and antagonists. In: Chabner BA, Knollmann BC, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011.
Woo T. Chapter 17. Drugs affecting the respiratory system. In: Pharmacotherapeutics for nurse practitioner prescribers. 3rd ed. Philadelphia: F.A. Davis Company; 2011.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Gelot, S., Wantuch, G., Zall, D. (2014). Oral Decongestants. In: Mackay, I.R., Rose, N.R., Ledford, D.K., Lockey, R.F. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9194-1_234
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9194-1_234
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9193-4
Online ISBN: 978-1-4614-9194-1
eBook Packages: MedicineReference Module Medicine